Close Menu

ASCO: No Benefit from Avastin in Glioblastoma

ASCO: No Benefit from Avastin in Glioblastoma. Patients with newly diagnosed glioblastoma lived no longer with the addition of bevacizumab (Avastin) to chemoradiation than they did without it, results of a large multicenter trial showed. SOURCE: Gilbert MR, et al “RTOG 0825: Phase III double-blind, placebo-controlled trial evaluating bevacizumab in patiens with newly diagnosed glioblastoma” ASCO 2013; Abstract 1.

Read more

Patient Portal Schedule an Appointment